Filtered By:
Specialty: Cardiology
Condition: Aortic Stenosis

This page shows you your search results in order of relevance. This is page number 7.

Order by Relevance | Date

Total 670 results found since Jan 2013.

Novel Cerebral Protection Technique During Right Transcarotid TAVR in Bicuspid Aortic Stenosis and Porcelain Aorta.
We report a case using cerebral embolic protection during a right transcarotid TAVR. PMID: 30373958 [PubMed - in process]
Source: The Journal of Invasive Cardiology - November 1, 2018 Category: Cardiology Tags: J Invasive Cardiol Source Type: research

Carotid plaque is a predictor of major adverse cardiac and cerebrovascular events in patients undergoing coronary angiography.
Conclusions: CP is an independent predictor of MACCE in patients undergoing coronary angiography. PMID: 30932085 [PubMed - in process]
Source: Archivos de Cardiologia de Mexico - April 2, 2019 Category: Cardiology Authors: Franco-Gutiérrez R, Pérez-Pérez AJ, Franco-Gutiérrez V, Ocaranza-Sánchez R, Testa-Fernández A, López-Reboiro ML, López-López A, Santás-Álvarez M, Crespo-Leiro MG, González-Juanatey C Tags: Arch Cardiol Mex Source Type: research

Clinical outcomes of self-expandable vs. balloon-expandable TAVI for severe aortic stenosis.
CONCLUSIONS: This real-world retrospective analysis demonstrates higher rates of ≥ moderate PAR, stroke and pacemaker insertion with SEV compared to BEV at 30 d post-TAVI for severe symptomatic AS. PMID: 30931804 [PubMed - as supplied by publisher]
Source: Acta Cardiologica - April 2, 2019 Category: Cardiology Tags: Acta Cardiol Source Type: research

Preventing brain embolism by using a modified isolation technique in transcatheter aortic valve implantation for a patient with shaggy and porcelain aorta
We report a case of TAVI in a shaggy and porcelain aorta and prevention of cerebral embolism by adopting a modified isolation technique without using conventional protection devices.>
Source: Journal of Cardiology Cases - May 2, 2019 Category: Cardiology Source Type: research

Carotid plaque is a predictor of major adverse cardiac and cerebrovascular events in patients undergoing coronary angiography.
Conclusions: CP is an independent predictor of MACCE in patients undergoing coronary angiography. PMID: 31448766 [PubMed - in process]
Source: Archivos de Cardiologia de Mexico - August 27, 2019 Category: Cardiology Authors: Franco-Gutiérrez R, Pérez-Pérez AJ, Franco-Gutiérrez V, Ocaranza-Sánchez R, Testa-Fernández A, López-Reboiro ML, López-López A, Santás-Álvarez M, Crespo-Leiro MG, González-Juanatey C Tags: Arch Cardiol Mex Source Type: research

Systematic Review and Meta-Analysis of Interventional Emergency Treatment of Decompensated Severe Aortic Stenosis.
CONCLUSION: Mortality in CS patients due to decompensated severe AS is high, regardless of interventional treatment strategy. Both eBAV and eTAVR seem feasible. As eTAVR is associated with better initial improvements in hemodynamics and simultaneously avoids sequential interventions, it might be favorable to eBAV in select patients. If eTAVR is not available, eBAV might serve as a "bridge" to elective TAVR. PMID: 31611428 [PubMed - as supplied by publisher]
Source: The Journal of Invasive Cardiology - October 16, 2019 Category: Cardiology Tags: J Invasive Cardiol Source Type: research

Should All Low-risk Patients Now Be Considered for TAVR? Operative Risk, Clinical, and Anatomic Considerations
This article reviews the current data on TAVR in low-risk patients with severe, symptomatic aortic stenosis, highlights the results of the recently published Medtronic Low Risk Randomized Study and PARTNER 3 trials, and describes specific clinical, anatomic, and procedural considerations regarding the optimal treatment choice in this population.Recent FindingsIn low-risk patients, the Medtronic Low Risk Randomized Study demonstrated TAVR to be non-inferior to surgery with respect to the composite endpoint of death or disabling stroke while PARTNER 3 trial proved TAVR to be superior to surgery with regard to the composite e...
Source: Current Cardiology Reports - November 27, 2019 Category: Cardiology Source Type: research

Differences in Flow-Gradient Patterns Between Severe Bicuspid Aortic Stenosis and Severe Tricuspid Aortic Stenosis 　- Mechanistic Insight From Multimodal Imaging.
CONCLUSIONS: Flow-gradient patterns in bicuspid AS differ from those of tricuspid AS and are associated with the structural and functional characteristics of the aorta. PMID: 31787664 [PubMed - as supplied by publisher]
Source: Circulation Journal - November 29, 2019 Category: Cardiology Authors: Kim D, Shim CY, Kim YJ, Nam K, Hong GR, Lee SH, Lee S, Ha JW Tags: Circ J Source Type: research

Transcatheter aortic valve replacement for patients with severe bicuspid aortic stenosis
ConclusionsThis initial experience suggests TAVR can be safely performed in patients with BAV achieving similar short-term procedural and clinical outcomes when compared with patients with TAV.Condensed AbstractThe outcomes of 50 patients (8.8%) with bicuspid aortic stenosis (BAV) undergoing TAVR were compared with those of 517 patients (91.2%) with trileaflet aortic valve (TAV) stenosis. Patients with BAV were younger, had higher prevalence of COPD, lower prevalence of CAD, higher BMI and lower STS score. Major complications were similar between the groups, including stroke (2.0% vs. 1.5, P = .567), 30-day all-c...
Source: American Heart Journal - February 9, 2020 Category: Cardiology Source Type: research

Valve-in-valve transcatheter aortic valve implantation after failed surgically implanted aortic bioprosthesis versus native transcatheter aortic valve implantation for aortic stenosis: Data from a nationwide analysis.
CONCLUSION: We observed that valve-in-valve TAVI was associated with good short- and long-term outcomes. No significant differences were observed compared with native valve TAVI regarding clinical follow-up. PMID: 32532695 [PubMed - as supplied by publisher]
Source: Archives of Cardiovascular Diseases - June 8, 2020 Category: Cardiology Authors: Deharo P, Bisson A, Herbert J, Lacour T, Saint Etienne C, Jaussaud N, Theron A, Collart F, Bourguignon T, Cuisset T, Fauchier L Tags: Arch Cardiovasc Dis Source Type: research

General versus Local Anesthesia with Conscious Sedation in Transcatheter Aortic Valve Implantation: The Randomized SOLVE-TAVI Trial.
Conclusions: Among patients with aortic stenosis undergoing transfemoral TAVR, use of CS compared with GA resulted in similar outcomes for the primary efficacy endpoint. These findings suggest that CS can be safely applied for TAVR. Clinical Trial Registration: URL: https://clinicaltrials.gov Unique Identifier: NCT02737150. PMID: 32819145 [PubMed - as supplied by publisher]
Source: Circulation - August 20, 2020 Category: Cardiology Authors: Thiele H, Kurz T, Feistritzer HJ, Stachel G, Hartung P, Lurz P, Eitel I, Marquetand C, Nef H, Doerr O, Vigelius-Rauch U, Lauten A, Landmesser U, Treskatsch S, Abdel-Wahab M, Sandri M, Holzhey D, Borger M, Ender J, Ince H, Öner A, Meyer-Saraei R, Hambrech Tags: Circulation Source Type: research

Outcomes of transfemoral transcatheter aortic valve implantation (TAVI) and predictors of thirty-day major adverse cardiovascular events (MACE) and one-year mortality.
CONCLUSION: We have shown excellent 30-day results with low incidence of adverse events with both the balloon expandable and self-expandable valves. Mainly clinical factors are predictors of both 30-day MACE and one-year mortality; major VC is a strong predictor of one-year mortality. PMID: 33007466 [PubMed - as supplied by publisher]
Source: Hellenic Journal of Cardiology - October 4, 2020 Category: Cardiology Tags: Hellenic J Cardiol Source Type: research

Risk of mortality following transcatheter aortic valve replacement for low-flow low-gradient aortic stenosis
ConclusionIn patients with LF-LG AS, history of myocardial infarction, renal dysfunction, tricuspid regurgitation, a low stroke volume index, self-expandable device, and non-femoral approach were associated with increased 1-year mortality after TAVR. The RRS might serve as a helpful tool for risk prediction and patient selection for TAVR in patients with LF-LG AS.
Source: Clinical Research in Cardiology - October 14, 2020 Category: Cardiology Source Type: research

Comparison of Self-Expanding Bioprostheses for Transcatheter Aortic Valve Replacement in Patients with Symptomatic Severe Aortic Stenosis: The SCOPE 2 Randomized Clinical Trial.
Conclusions: Transfemoral TAVR with the self-expanding ACURATE neo did not meet non-inferiority compared to the self-expanding CoreValve Evolut in terms of all-cause death or stroke at 1 year, and was associated with a lower incidence of new permanent pacemaker implantation. In secondary analyses, the ACURATE neo was associated with more moderate or severe aortic regurgitation at 30 days and cardiac death at 30 days and 1 year. Clinical Trial Registration: URL: https://clinicaltrials.gov/ Unique Identifier: NCT03192813. PMID: 33054367 [PubMed - as supplied by publisher]
Source: Circulation - October 15, 2020 Category: Cardiology Authors: Tamburino C, Bleiziffer S, Thiele H, Scholtz S, Hildick-Smith D, Cunnington M, Wolf A, Barbanti M, Tchetché D, Garot P, Pagnotta P, Gilard M, Bedogni F, Van Belle E, Vasa-Nicotera M, Chieffo A, Deutsch O, Kempfert J, Søndergaard L, Butter C, Trillo-Nouc Tags: Circulation Source Type: research

Clinical Outcomes in Patients Treated With a Repositionable and Fully Retrievable Aortic Valve 　- REPRISE Japan Study.
CONCLUSIONS: Data from REPRISE Japan confirm the safety and efficacy of the LOTUS Valve when used in Japanese clinical practice. PMID: 33191317 [PubMed - as supplied by publisher]
Source: Circulation Journal - November 14, 2020 Category: Cardiology Authors: Saito S, Hayashida K, Takayama M, Goto T, Ihlberg L, Sawa Y Tags: Circ J Source Type: research